Sangeetha Sundaramoorthy has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sangeetha Sundaramoorthy, a member of the promoter group of Lotus Eye Hospital and Institute Limited, has submitted a disclosure under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation typically applies to inter se transfers of shares among promoters or promoter group entities. The specific details of the transaction — including number of shares, direction (buy or sell), and revised shareholding — are not mentioned in the headline provided.
This is a routine regulatory disclosure related to an internal reshuffle of shares within the promoter group. Without further details on the quantum or direction, there is no clear material impact on the company's public shareholding structure or minority shareholders at this stage.